real-time news and commentary for investors
Wednesday, Oct 16
Meeting between MiMedx and FDA postponed
- MiMedx Group (MDXG) says its meeting with the FDA (scheduled for today) regarding the letter the company received early last month has been postponed due to the government shutdown.
- "As part of the partial Federal government shutdown, some of the key participants in the meeting remain on furlough," CEO Parker Petit says.
- The regulator did not say when the rescheduled meeting would be held.
- For more on the HCT/P issue, see here.